4-Oxoretinol - Potential New Cancer Therapeutic Drug

Lane, Michelle A.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Postdoctoral Individual National Research Service Award (F32)
• Project #: 5F32CA075722-03
• Application #: 6172700
• Study Section: Special Emphasis Panel (ZRG2-SSS-1 (01))
• Program Officer: Lohrey, Nancy
• Project Start: 2000-08-10
• Budget Start: 2000-08-10
• Budget End: 2001-07-31
• Support Year: 3
• Fiscal Year: 2000
• Total Cost: $40,013

Institution

• Name: Weill Medical College of Cornell University
• Department: Pharmacology
• Type: Schools of Medicine
• DUNS #: 201373169
• City: New York
• State: NY
• Country: United States
• Zip Code: 10065

Publications

Lane, Michelle A; Xu, Juliana; Wilen, Elana W et al. (2008) LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol. Mol Cell Endocrinol 280:63-74